Using classical homeopathy helps lower blood pressure, lowers cholesterol and lowers the risk of stroke and heart attack. It can also help with angina, tachycardia, and helps maintain the overall healthy function of your heart and arteries. Our medicines can be used along with standard heart medications.
A combination of proper diet, such as the Metabolic Balance program, exercise, and classical homeopathic treatment is the most effective solution for heart problems. In order for treatment to be effective, an appointment should be made at the clinic.
Scientific Studies Prove the Effectiveness of Homeopathy for Controlling High Blood Pressure / Hypertension, Tachycardia, Heart Rate and Mild Cardiac Insufficiency
Campistranous- Lavout JL., et al. “Hypertension Trial.” Boletin Mexicano, 1999, 32, 42- 47.
68 people suffering from mild to moderate hypertension were enrolled in a double-blind randomised clinical trial comparing individualised homoeopathic therapy with placebo. Successful results were obtained with 82% of those using homoeopathy compared with 57% of those using placebo.
Researchers in this controlled study attempted to determine the effects of potentised aspirin on rats exhibiting reduced platelet aggregation associated with portal hypertension. Given that material doses of aspirin are known to be associated with a reduction in platelet aggregation, one of the aims of the study was to confirm that the reverse of this would be the case with if potentised aspirin were used. The researchers did, in fact, confirm this in their results which showed that, compared to controls, Aspirin 14C normalised deficiencies in platelet aggregation in the rats involved in this study.
Abstract
AIM: To study the mechanism involved in the potentially beneficial effect of ultra low dose aspirin (ULDA, homeopathic aspirin 14C) in prehepatic portal hypertension, rats were pretreated with selective COX 1 or 2 inhibitors (SC-560 or NS-398 respectively), and subsequently injected with ULDA or placebo.
METHODS: Portal hypertension was induced by portal vein ligation. Platelet activity was investigated with an in-vivo model of laser induced thrombus production in mesenteric circulation and induced hemorrhagic time (IHT). Platelet aggregation induced by ADP and dosing of prostanoid products 6-keto-PGF1a, TXB2, PGE2 and LTB4 were also performed.
RESULTS: The portal hypertensive group receiving a placebo showed a decreased in vivo platelet activity with prolonged IHT, an effect that was normalized by ULDA. SC-560 induced a mild antithrombotic effect in the normal rats, and an unmodified effect of ULDA. NS-398 had a mild prothrombotic action in portal hypertensive rats, similar to ULDA, but inhibited a further effect when ULDA was added. An increased 6-keto-PGF1a was observed in portal hypertensive group that was normalised after ULDA administration. TXA2 level after ULDA, remained unchanged.
CONCLUSION: These results suggest that the effect of ULDA on platelet activity in portal hypertensive rats, could act through a COX 2 pathway more than the COX 1, predominant for aspirin at higher doses.
Abstract
Ultra-low-dose aspirin has shown a prothrombotic effect in the laser-induced thrombosis model. Several studies of our laboratory have shown a positive effect in rats with two different experimental models of portal hypertension: portal vein ligation, a model with an almost normal liver, and 30 days of bile duct ligation, a model with cirrhosis and presence of ascitis. In both models of portal hypertensive rats, bleeding time was prolonged and thrombi formation, in a laser-induced model of thrombi production, decreased. The hypotheses of the presented studies were that ultra-low-dose aspirin [homeopathic aspirin 15C] could decrease the bleeding complications in these models and that the mechanism for these effects could act thorough the COX pathway. In different studies, ultra-low dose of aspirin normalized the induced hemorrhage time, thrombi production, and platelet-endothelial cell interaction. The possible beneficial role of these doses of aspirin and mechanism of COX 2 inhibition are discussed.
Aims and objectives: The primary objective of the study was to evaluate and document the evidence-based efficacy and safety of the study drug in lowering blood pressure (BP). The secondary objectives included efficacy of the study drug in improving symptoms, quality-of-life (QOL) and biochemical parameters including treadmill and Doppler echocardiography.
Study design: Phase IV post-marketing/surveillance study.
Material and methods: Thirty-five subjects with prehypertension and hypertension (Stage 1 and Stage 2), attending the OPDs and camps of Heart Care Foundation of India were enrolled for the nonplacebo-controlled prospective study. The subjects were given homeopathic combination BPA (study drug) in liquid dosage for 12 weeks. Baseline clinical and biochemical parameters, treadmill test and Doppler echocardiogram were compared with the same parameters at the end of 12 weeks. Sixteen subjects completed the study.
Results: There was a mean fall in systolic BP (SBP) of 15.75 mmHg and mean fall in diastolic BP (DBP) of 10.31 mmHg without any side effects. This significant decline in BP was evident from 4th week onwards. There was an appreciable increase in the exercise tolerance as evident by the 8.6% increase in metabolic equivalents (METs) and 8.2% increase in exercise time. No significant changes were observed in systolic or diastolic function parameters on Doppler echocardiography at three months. There was decrease in blood sugar from 96.5 ± 13.938 at baseline to 92.56 ±12.329 at 12 weeks (p = 0.046). Serum uric acid levels also decreased from 5.681 ± 0.8998 at baseline to 6.031 ± 0.8822 at 12 weeks (p = 0.053) suggesting a beneficial effect of the combination on insulin resistance (IR). There were positive changes in the QOL as assessed by SF36 Questionnaire. The average Rand score improved from 54.53 ± 21.9991 to 77.55 ± 10.493 at 12 weeks (p < 0.001). All data are presented as mean ± standard deviation (SD).
Conclusion: The results of the study showed that the study drug can be safely used as monotherapy in patients with prehypertension or hypertension with no complications.
Hitzenberger G, Kom A, Dorsci M, Bauer P, Wohlzogen FX. “Controlled randomised Double Blind study for the Comparison of the Treatment of Patients with Essential Hypertension with Homoeopathic and Pharmacologically Effective Drugs.” Weiner Klinische Wochenschrift (Klinische Wochenschrift), 1982, 94, 24, 665-670.
In this randomized double-blind cross-over trial, 10 people suffering from essential hypertension were treated either with standard pharmaceutical products or homeopathic medicines. Pharmaceuticals were found to provide superior blood pressure reducing effects but homeopathic were found to be the better choice for the management of the subjective symptoms of hypertension.
An exploratory interventional study was conducted at Dharam Kiran Govt. Homoeopathic Hospital, Hyderabad, India, from 2004 to 2006. Thirty patients with hypertension were enrolled from the hospital outpatient department. Detailed case history was recorded as per the standard format. The cases were subjected to repertory analysis, and the final selection of medicines was performed on an individual basis following consultation of the homeopathic materia medica.
Sixteen (53.33%) cases showed marked improvement, 8 (26.67%) moderate improvement, 3 (10%) no improvement and 3 (10%) dropped out. (Figure 1) Arsenicum album, Natrum muraticum, Nux vomica, Causticum and Lycopodium clavatum were found to be useful in the management of essential hypertension. The difference in the systolic and diastolic blood pressure before and after treatment was statistically significant (p<0.001).
Background: The action of homeopathic medicines, in ultra-high dilution, is not directly observable. An attempt was made to explore autonomic response of selective homeopathic medicines, in healthy persons, using Medical Analyzer System (Electronics Division, Bhabha Atomic Research Centre, Mumbai, India).
Objective: The objective of the study was to observe the action of homeopathic medicines on physiologic variability of heart rate and blood flow. Material and methods: Pre- and postinterventional variability spectra of heart rate and blood flow of 77 subjects were recorded with the Medical Analyzer System, administering homeopathic preparations of Aconitum napellus (6c, 10M), Arsenicum album (200c, 1M), Gelsemium sempervirens (200c, 1M), Phosphorus (200c, 1M), Pulsatilla nigricans (200c) and Sulphur (200c, 1M) versus placebo control. The amplitude of the peaks viz. low-frequency, medium-frequency, and high-frequency was measured for postintervention analysis. An increase in the amplitude of any valid peak by 100% or a decrease by 50% was considered as significant change.
Results: Aconitum napellus produced a response in heart rate variability (HRV) with 30c potency and in blood flow variability with 1M potency. Sulphur 200c and 1M, Gelsemium 200c and Pulsatilla 200c, produced a 62.5% response in HRV against the placebo response of 16.6%. Gelsemium, Phosphorus, and Sulphur produced a response in blood flow variability with a 1M potency, similar to the response of Aconitum napellus 1M.
Conclusions: These data suggest that it is possible to record the response of homeopathic medicines on physiologic parameters of the autonomic nervous system.
Abstract
Viscum album, an infrequently used antihypertensive in homeopathy, is evaluated by 1-group pretest-posttest model in primary hypertension. The drug was administered for 12 weeks at a dosage of 10 drops 3 times a day. Using paired t test, a significant drop in blood pressure (P < .0001) and serum triglyceride (P < .0001) was observed in the treatment group. This dual effect of Viscum album shows promise in optimizing therapy for primary hypertension.
Abstract
Background: Hypertension is the most common cardiovascular disorder posing a major public health challenge to the population. Homoeopathy, although widely used in hypertension, is assumed to have nothing but placebo effects and its specific clinical effects are frequently ascribed as implausible.
Aims: To evaluate whether individualized homoeopathy can produce any significant effect different from placebo in essential hypertension by comparing the lowering of blood pressure between groups.
Settings and Design: A prospective, double-blind, randomized, placebo-controlled, parallel-arm clinical trial was conducted at the Outpatient Clinic of the Mahesh Bhattacharyya Homoeopathy Medical College and Hospital, West Bengal.
Material and Methods: Out of 233 hypertensives assessed for eligibility, 150 were enrolled and randomized (verum/homoeopathy 70, control/placebo 80). A total of 18 dropped out and 132 were regular (verum 64, control 68). The outcome measures were assessed after three months and six months.
Statistical Analysis: The intention-to-treat population was subjected to statistical analysis. Group differences were tested using the χ2 test and independent t test. Repeated measure (ANOVA) was performed to compare the data of two groups obtained longitudinally at baseline, three months and six months.
Results: The baseline data were not significantly different between the groups. After six months, mean Systolic Blood Pressure (SBP) reduction was 26.6 mm Hg (95% CI 21.5, 31.7) in the homoeopathy group and SBP increased by 3.6 mm Hg (95% CI -8.7, 1.5) in the placebo group. Similarly, the mean Diastolic Blood Pressure (SBP) in the homoeopathy group reduced by 11.8 mm Hg (95% CI 9.2, 14.4) and increased by 1.6 mm Hg (95% CI -3.6, 0.4) in the placebo group. Repeated measures ANOVA also showed significant difference (P=0.0001) between the groups. Natrum muriaticum, Calcarea carbonica, Sulphur, Thuja occidentalis, Nitric acid and Medorrhinum were frequently prescribed.
Conclusion: Individualized homoeopathy produced a significantly different hypotensive effect than placebo.
Schroder D, Weiser M, Klein P. “Efficacy of a Homeopathic Crataegus preparation compared with usual therapy for Mild Cardiac Insufficiency: Results of an Observational Cohort Study.” European Journal of Heart Failure, 2003, June, 5, 3, 319-26.
In a non-randomised cohort study, 212 people suffering from mild cardiac insufficiency were given Cralonin, a homoeopathic combination product, or a combination of an ACE inhibitor and diuretic (a combination medical therapy normally prescribed for this condition). Both products were similarly effective in controlling the condition.
Homeopathically prepared Digitalis 6C is a common prescription for those suffering from atrial tachycardia. This paper reports on the effects of Digitalis 6C, given at the Division of Medicine of the Indian Veterinary Research Institute in Izatnagar in India, to a Labrador dog and a German Shepherd dog, both of which were suffering from atrial paroxysmal tachycardia. Both dogs were given 4 drops of the medicine 4 times daily and their ECGs were assessed after 7 days of continuous treatment. At this point it was found that the heart rates of both dogs was stabilised and synchronized, with atrial and ventricular electrical activity appearing to be functioning normally.
HYPERTENSION AND HOMEOPATHY: A CASE STUDY BY Mahnaz Shahrzad Asr, D.H.M.H.S, H.D., C.B.P.
A 52-year-old woman came to my clinic complaining of hot flashes and fibromyalgia. She had been using hypertension drugs for five years, which had stabilized her situation without any symptoms. Her blood pressure was 130/95 with the use of Losartan, an anti-hypertension drug.
I prescribed homeopathic Galeo-C. This remedy was chosen because it matched both her disease picture (hot flashes, constipation, etc.) and her personality (a need to be in control; stress related to eating). Potency: 200 C; one dose every 3 weeks for two months.
First follow-up: After the first dose, her hot flashes had subsided and her fibromyalgia pain had decreased to some extent. Her knees, elbows, wrists, and shoulders felt fine, and the only problem was pain in her thumb and middle finger. Plan: Repeat the same remedy. Potency – same.
Second follow-up: The patient returned to my clinic two months after last follow-up. She was very happy, and said that two weeks prior, when she took the second dose of remedy, she was hospitalized due to abnormally low blood pressure. Her doctor suggested that she stop taking her blood pressure drugs and so she did. Her blood pressure was now 110/90, she still had pain in her joints, and her fibromyalgia still bothered her. Plan: Repeat the same remedy; Potency – same.
Third follow-up: The patient returned to my clinic, very happy and calm. Her blood pressure had dropped to 100/75 (she mentioned before her hypertension troubles that her blood pressure reading was always low) so she had returned to her previous health state wherein her blood pressure was completely stabilized. Her only problem was painful tendonitis in her thumb. She was no longer experiencing hot flashes, fibromyalgia, or hypertension. Plan – wait
Fourth follow-up: At this point, the patient’s constipation was much better – she decreased her intake of a laxative herb, and no longer suffered from headache, hot flashes, or fibromyalgia. Her only remaining problems were the ganglion on her wrist, and tendonitis. Her blood pressure was now stable at 110/80. Plan: Calc-f tissue salt